{
    "eid": "2-s2.0-85121904296",
    "title": "Clinical outcome of Yttrium-90 selective internal radiation therapy (Y-90 SIRT) in unresectable hepatocellular carcinoma: Experience from a tertiary care center",
    "cover-date": "2022-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Liver cancer",
        "Survival outcome",
        "Transarterial radioembolization (TARE)",
        "Unresectable hepatocellular carcinoma",
        "Yttrium-90 selective internal radiation therapy (Y-90 SIRT)"
    ],
    "authors": [
        "Jukkaphop Chaikajornwat",
        "Wasu Tanasoontrarat",
        "Chonlada Phathong",
        "Nutcha Pinjaroen",
        "Roongruedee Chaiteerakij"
    ],
    "citedby-count": 1,
    "ref-count": 35,
    "ref-list": [
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Hepatocellular carcinoma",
        "Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma",
        "Advanced hepatocellular carcinoma tumor stage at diagnosis in the 1945-1965 birth cohort reflects poor use of hepatocellular carcinoma screening",
        "Transarterial radioembolization with Yttrium-90 for the treatment of hepatocellular carcinoma",
        "Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres)",
        "Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma",
        "In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?",
        "Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization",
        "Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma",
        "AASLD guidelines for the treatment of hepatocellular carcinoma",
        "Asia-pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update",
        "A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization",
        "Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis",
        "Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial",
        "Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: the impact of portal vein thrombosis on survival",
        "Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours",
        "Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma: a single center 14 years experience from China",
        "Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival",
        "Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation",
        "Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study",
        "Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes",
        "Real-world data for the evaluation of transarterial radioembolization versus sorafenib in hepatocellular carcinoma: a cost-effectiveness analysis",
        "Sorafenib in advanced hepatocellular carcinoma",
        "Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy",
        "Prospective randomized pilot study of Y90+/-sorafenib as bridge to transplantation in hepatocellular carcinoma",
        "Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience",
        "90Y radioembolization for locally advanced hepatocellular carcinoma with portal vein thrombosis: long-term outcomes in a 185-patient cohort",
        "Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma",
        "Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis",
        "Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma",
        "Selective internal radiation therapy using yttrium-90 resin microspheres in patients with unresectable hepatocellular carcinoma: a retrospective study",
        "Effect of yttrium-90 radioembolization on outcomes in Asian patients with early to advanced stage hepatocellular carcinoma",
        "Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinoma",
        "Exploring intra- and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Department of Medicine, Faculty of Medicine, Chulalongkorn University",
        "Chulalongkorn University"
    ]
}